@dhovekamp42 Three of the 19 patients with ongoing CR had prolonged cytopenia without evidence of MDS after receiving CAR-T cells. Subsequent MDS occurred in four patients, and notably, two of these had cytogenetics abnormalities prior to CAR-T cell therap
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review https://t.co/OAj7dhusZB https://t.co/rXaE4eQuHZ
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review #lymphoma #lymsm https://t.co/bzHMaJvpop
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review https://t.co/1PF5yP3aaI https://t.co/VNnxIswTiX